226 results
424B3
APDN
Applied Dna Sciences Inc
20 Mar 24
Prospectus supplement
5:00pm
healthcare costs, reduce adverse drug events, and increase overall population wellbeing. These benefits can result in significant cost savings to large … strategy is substantially dependent;
whether we are able to achieve the benefits expected from the acquisition of Spindle;
the effect of governmental
424B5
idi7f i354hp0
1 Feb 24
Prospectus supplement for primary offering
4:05pm
8-K
EX-4.1
6hp4 gcs0ee4g
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
8-K
EX-10.2
wn5freoazumfbfg4
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
8-K
EX-4.2
5h8nrxnhn s5irkx
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
8-K
EX-10.1
5hk81t2toslwde5ys
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
8-K
EX-10.1
trcrkiwdp5l67u5
7 Nov 23
Entry into a Material Definitive Agreement
5:09pm
424B5
oqq r01u3v
7 Nov 23
Prospectus supplement for primary offering
5:02pm
8-K
EX-2.1
kd03a
13 Jul 23
Entry into a Material Definitive Agreement
5:04pm
8-K
EX-99.2
44ynd61ote8p75
13 Jul 23
Entry into a Material Definitive Agreement
5:04pm